Nalbuphine for Cough Caused by Idiopathic Pulmonary Fibrosis—Reply
AI Summary
The study reveals promising results for nalbuphine ER as a treatment for cough associated with idiopathic pulmonary fibrosis, demonstrating significant reductions in both objective and patient-reported cough frequency and severity. This is crucial as it offers a potential new therapeutic option for a condition that currently lacks effective management of its distressing cough symptom. The findings could lead to improved quality of life for patients suffering from this debilitating disease.
Original Source
Read the full article at Jamanetwork →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.